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Introduction
Loss of hair cells (HCs) and spiral ganglion neurons (SGN) is the major cause of agerelated hearing loss (ARHL), i.e., presbycusis which normally affects high frequencies first (Schacht and Hawkins, 2005) and displays a prevalence of > 50 % in populations > 75 years of age (Gates and Mills, 2005) . Calcium dyshomeostasis was proven to be of central relevance for age-and noise-related impairment of neuroacoustic function (Bao et al., 2005 , Buchholz et al., 2007 with different types of voltage-gated Ca 2+ channels (VGCCs) being expressed in inner and outer hair cells (OHCs and IHC, respectively), SGNs, the cochlear nucleus, the trapezoid body, the lateral superior olive (LSO) and further ascending components (Lopez et al., 2003 , Shen et al., 2007 , Nie et al., 2008 , Simms and Zamponi, 2014 , Zamponi, 2016 VGCC was the first to be correlated with auditory dysfunction, as ablation of Ca v 1.3 in mice results in degeneration of IHCs and OHCs with subsequent deafness (Platzer et al., 2000 , Glueckert et al., 2003 . In addition, Ca v 1.3 was shown to be involved in the activity-dependent development of the auditory brainstem, evidenced by Ca v 1.3 deficient mice exhibiting a dramatic volume reduction in all auditory brainstem centers that occurred even before hearing onset (Hirtz et al., 2011) . Thus, VGCC dysfunction can cause severe functional and developmental alterations in the peripheral auditory tract due to a highly complex and fine-tuned system of balanced Ca 2+ influx that regulates spatiotemporal auditory processing.
Based on in vitro and in vivo findings on HC physiology, Ca v 1.3 VGCCs were originally considered potential candidates for the etiopathogenesis of ARHL and noise-induced hearing loss (NIHL) as well as targets for their prevention and therapy.
Interestingly, age-related increases in brainstem-evoked response audiometry (BERA) thresholds turned out to be associated with a gradual decrease of Ca v 1.3 expression in IHC, OHC and the stria vascularis supporting a potential role for Ca v 1.3
in ARHL (Chen et al., 2013) . Initially, it was suggested that only L-type VGCCs are involved in acoustic injury of the cochlea, such as L-type blockers, e.g., diltiazem, verapamil and dihydropyridines (DHPs), but not T-type blockers such as mibefradil
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5 and flunarizine, seemed to decrease HC loss (Mills et al., 1999 , Uemaetomari et al., 2009 ).
However, T-type VGCCs also exhibit complex spatiotemporal expression patterns in the auditory system, e.g., HCs (Inagaki et al., 2008) , the cochlear nucleus (Kim and Trussell, 2007) , the superior paraolivary nucleus (SPON) (Felix et al., 2011) , and the LSO (Adam et al., 2001) . Early immunohistochemical studies in 2 month old C57Bl/6 mice suggested weak Ca v 3.1 and Ca v 3.3, but no Ca v 3.2, VGCC expression in the organ of Corti. SGNs, however, exhibit dominant Ca v 3.2 with only moderate Ca v 3.1
and Ca v 3.3 expression (Shen et al., 2007) . Whole cochlear qPCR in the same setting revealed highest transcript levels for Ca v 3.2 exceeding those for Ca v 3.1 and Ca v 3.3 by 2-fold and 100-fold, respectively (Shen et al., 2007) . Additionally, no gender specific differences in expression levels were detected. Further quantification of Ttype Ca 2+ channels in the cochlea of young 6 -8 wk old C57Bl/6J mice again revealed transcripts of all three T-type Ca 2+ channels with Ca v 3.2 exhibiting the lowest expression (Yu et al., 2016) . Lei et al. (2011) analyzed all three Ca v 3 T-type channel transcript levels in C57Bl/6 cochlea at 2, 4 and 8 months of age in which Ca v 3.2 levels clearly predominated and increased with age (Lei et al., 2011) . This tendency was later confirmed for SGNs in C57Bl/6 mice aged 6 -44 wks in which Ca v 3.2 transcripts also predominated (Yu et al., 2015) . Thus Ca v 3 Ca 2+ channels, particularly Ca v 3.2, display a complex developmental, i.e., spatiotemporal expression pattern within the cochlea.
Importantly, it was shown in 9 -11 month old mice that ablation of Ca v 3.2 results in a significant delay of age-related loss of cochlear function and preservation of SGNs, further stressing a potential role for Ca v 3.2 in ARHL (Lei et al., 2011) . Consequently, Ca 2+ channel blockers and antiepileptic drugs (AEDs) known to inhibit T-type Ca 2+ channels, e.g., trimethadione, ethosuximide, and flunarizine, were shown to preserve SGNs during aging (Mills et al., 1999 , So et al., 2005 , Shen et al., 2007 , Lei et al., 2011 . This prophylactic and therapeutic effect of AEDs that block T-type VGCCs was later also confirmed for NIHL (Bao et al., 2013 , Yu et al., 2016 and it was suggested that multi-drug-multi-target therapeutic approaches including block of Ttype VGCCs e.g., via ethosuximide (Gomora et al., 2001 ) and zonisamide (Matar et al., 2009) in combination with dexamethasone, could be a feasible approach for NIHL treatment as well (Bao et al., 2013) . Notably, the positive effects of HC preservation and hearing threshold consolidation in ARHL and NIHL models seem to be age-
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8 Genotyping Ca v 3.2 mutant mice were genotyped by PCR based on the protocol of the KAPA Mouse genotyping kit (Sigma Aldrich, Germany). The following primers were used:
WT-forward: 5'-ATT CAA GGG CTT CCA CAG GGT A-3', WT-reverse/KO-forward:
5'-CAT CTC AGG GCC TCT GGA CCA C-3', KO-reverse: 5'-GCT AAA GCG CAT GCT CCA GAC TG -3' (see also Chen et al., 2003) . PCRs were performed using a C1000 thermal cycler (BioRad, Germany) with initial denaturation (95°C -1 min), followed by 35 cycles (denaturation 95°C -15 sec, annealing 61°C -15 sec, extension 72°C -1 min) and final extension (72°C -10 min). Subsequently, PCR products were separated via agarose gel electrophoresis and detected by ChemiDoc Touch (BioRad, Germany) ( Fig. 1) .
ABR recording procedure
Prior to ABR recordings, animals were anesthetized using intraperitoneal (i.p.)
injection of ketamine (100 mg/kg body weight, Ketanest ® S, 25 mg/ml Pfizer, Germany) and xylazine (10 mg/kg body weight, Rompun ® 2%, Bayer, Germany) and placed inside a sound attenuating cubicle (ENV-018V, Med Association, Inc., USA)
lined with an acoustic foam. The entire cubicle was covered with a custom made meshed metal Faraday cage (stainless steel, 2 mm thickness, 1 cm mesh size) to shield ABR recordings from external electrical interference and to protect from noise.
Following anesthesia, animals were placed on a homeothermic heating blanket For recording of monaural bioelectrical auditory potentials, subdermal stainless steel electrodes (27GA 12 mm, Rochester Electro-Medical, USA) were inserted at the vertex, axial to the pinnae (positive (+) electrode) and ventrolateral to the right pinna (negative (-) electrode) (Fig. 2) . The ground electrode was positioned at the hip of the animal. Impedance measurements of all electrodes were performed prior to each recording to verify proper electrode positioning / conductivity and were set < 5 kΩ. All
ABR recordings were performed under free field conditions using a single ABR data acquisition was performed at a sampling rate of 24.4 kHz, and signals were bandpass filtered (high pass 300 Hz, low pass 5 kHz) using a 6-pole Butterworth filter. Individual ABR data acquisition time was 25 ms, starting with a 5 ms baseline period prior to the individual acoustic stimulus onset (pre ABR baseline) and exceeding the 10 ms ABR section by another 10 ms baseline (post ABR baseline,
Fig. 2).
Two types of acoustic stimuli were used in this study and were generated using The frequency range was studied from 1 -42 kHz in 6 kHz steps. All acoustic stimuli were applied 300 times at a rate of 20 Hz and averaged. For ABR threshold recordings, sound pressure levels (SPL) were increased in 5 dB steps for clicks and 10 dB steps for tone bursts (Willott, 2001 , Scimemi et al., 2014 , Rotschafer et al., 2015 , Tucker-Davis Technologies, 2015 , starting from 0 dB up to 90 dB (increasing SPL mode). Note that SPLs for tone bursts within the range of 1 -42 kHz were calibrated each day prior to recording using a microphone (378C01, PCB Pieztronics, 
ABR analysis -General aspects and software
To avoid potential inconsistencies in ABR threshold determination by visual inspection/estimation, we performed automated threshold detection based on earlier publications (Bogaerts et al., 2009 , Probst et al., 2013 , Alvarado et al., 2014 . For data processing and analysis, "R" software (The R Foundation, version 3.2.1, R Core
Team 2015) was used with additional packages, including "reshape2" (version 1.4.1), "ggplot2" (version 1.0.1), "data.table" (version 1.9.4), "gdata" (version 2.13.3),
"pastecs" (version 1.3.18), "waveslim" (version 1.7.5) and "MassSpecWavelet"
(version 1.30.0; (Du et al., 2006) . Wavelet analysis was performed using the "MassSpecWavelet" package (Du et al., 2006) .
Analysis of hearing thresholds
To determine the click and tone burst derived thresholds of ABR recordings, three distinct time windows (TWs) were set to calculate the signal to noise ratio (SNR), i.e., TW 1 (pre stimulus, 0 -5 ms), TW 2 (stimulus related, 5 -15 ms) and TW 3 (post stimulus, 15 -25 ms). Noise standard deviation of the baseline was calculated within two distinct TWs, i.e., TW1 and TW3 where no auditory evoked potentials (AEP)
were observed ( Fig. 2A) . For each SPL measurement within an ABR record setting both mean and standard deviation were calculated for pooled TW 1 and TW 3 data.
Subsequently, all recording samples were reset individually by the corresponding calculated mean. The threshold of hearing (TH) was determined by the lowest SPL frequency threshold analysis at maximum SPL, a nominal threshold level of 100 dB was assigned.
ABR wave amplitude and wave latency analysis
To determine the temporal collocation of all positive (p) waves (peaks, see intercept points of red-grey lines with ABR trace) as well as negative (n) waves (pits, see intercept points of blue-orange lines with ABR trace, Fig. 2A ), a "Mexican hat" wavelet based analysis was conducted which uses a default wavelet by the continuous wavelet transform (CWT)-based pattern-matching algorithm (Du et al., 2006) . Mathematically, the CWT is represented as (Daubechies, 1992) , see also (Valderrama et al., 2014) :
where s(t) is the signal, a is the scale, b is the translation, (t) is the mother wavelet, a,b (t) is the scaled and translated wavelet and C is the 2D matrix of wavelet coefficients.
In an initial step, a 65 dB measurement of each ABR run was used to identify the best scale parameters for each wave to be passed to the CWT, resulting in three classes: scale parameters 0.5 -4 for all n-waves, 0.5 -6 for all p-waves and 0.5 -12 for wave IV, as this was the broadest wave within the samples. All classes proved to reliably detect the correct temporal collocation of waves I -IV within all 65 dB measurements.
To determine ABR waves I -IV in the accurate temporal sequence at 65 dB SPL, ppeaks ( Fig. 2A , red-grey lines) and n-peaks (pits, Fig. 2A , yellow-blue lines) were identified in a fixed progression using relative positions of previously identified peaks to limit the TW of subsequent scans. Once all nine peaks had been characterized at 65 dB ( Fig. 2A) , these values were used as references (starting points) for the temporal search frame for adjacent sound pressure measurements (60 dB and 70 dB) before identification of peaks 1 -9 was reinitiated. Accordingly, p-and n-peaks for all dB SPLs (65 -0 dB and 70 -90 dB) were determined if possible. Once a p-
and n-peak were no longer identifiable by wavelet analysis, their temporal collocation was set by calculating the temporal offset of the peak to any other peak identified in the previous dB level. Applying the temporal offset of peaks to any other p-and npeak within the current dB level resulted in a maximum of eight determined temporal positions for the undefined peaks in which the mean was taken as the closest approximation.
To evaluate amplitude growth function and latency comparison of all waves (W I-IV ), maximum amplitudes ( Fig. 2A , green crosses) and mean latencies ( Fig. 2A , red-grey lines) of each of the four p-peaks within the time frame of the related n-peaks were further evaluated. Importantly, all results based on the self-programmed automatic wavelet tool were subsequently visually confirmed based on an independent, blinded manual ABR analysis performed by a different investigator. In rare cases, individual ABR runs were excluded from statistics due to, for example, noise contamination.
Note that our approach determines "Mexican hat" wavelet based time frames of each wave (W I-IV ) for subsequent identification of the actual maxima and related latencies.
This is similar to a recent study by Valderrana et al. (2014) that applies a "Mexican hat" based fitted parametric peaks (FPP) approach using synthesized peaks (Valderrama et al., 2014) . Note that experimental animals for cochlear qPCR analysis were not involved in ABR experiments to eliminate potential confounding factors.
Real time PCR of
Both cochleae of each individual animal were dissected in an RNase free environment (RNAlater ® stabilization reagent, Qiagen, Germany) and snap-frozen in liquid nitrogen. Total RNA from both mouse cochleae was extracted using Direct- Scientific; Germany). Quality and quantity of total RNA was evaluated using Nanodrop standard procedures (Nanodrop TM 1000, Thermo Fisher Scientific, Germany). cDNA synthesis was performed via a two-step RT-PCR approach using both random hexamer and anchored-oligo(dt) 18 primers with 250 ng total cochlear RNA from each animal for the final 50 l first-strand cDNA mix (Transcriptor FirstStrand cDNA synthesis Kit, Roche, Germany). cDNA (2 l) served as a template for qPCR (see below), and signal detection was based on SYBR Green I Master (Roche, Germany). qPCR experiments were carried out using a LightCycler 480 System (Roche, Germany) with the following protocol (per cycle) being applied for all primer pairs (Tab. 1): 95°C (10 min, pre-incubation step); 95°C (10 s, denaturation step); 60°C (20 s, annealing step); 72°C (30 s, extension step). Forty total cycles were performed.
Every cochlea sample was tested in triplicate, and two negative controls were added in duplicate, (no template; no RT) for the qPCR 96-well-plate (Roche, Germany).
Furthermore, to avoid inter-run variations and ensure statistical comparability among the plates, cochlea cDNA derived from C57Bl6/J mice served as a positive control and calibrator cDNA and was also used in triplicate on every plate. Amplification specificity was verified by melting curve analysis (LightCycler480 System Software, Roche). Deionized, nuclease-free water (no cDNA) and total RNA samples (without RT) were used as controls, and HPRT was utilized as an internal reference gene. Ctvalues (cycle threshold) were calculated using the LightCycler 480 System software (Roche).
Individual primer efficiency, analysis and qPCR statistics were performed using qBase+ qPCR analysis software (Biogazelle, Gent, Belgium) which is based on a delta-Cq quantification model with PCR efficiency correction, reference gene normalization and inter-run calibration (Hellemans et al., 2007) . All results were determined as CNRQ (Calibrated Normalized Relative Quantity) and statistically analyzed using the Mann-Whitney test.
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Statistical analysis
All results in this study are presented as group means ± SEM using GraphPad Prism 6 software (V6.07 GraphPad Software, Inc., USA). Both genders were analyzed separately. Significant differences were compared using an ordinary one-way ANOVA for click-evoked hearing threshold analysis (Fig. 8) and latency analysis for each single wave (Fig. 12) followed by Tukey's multiple comparisons test. Two-way repeated measure ANOVA followed by Tukey's adjustment for multiple comparisons was performed to evaluate differences in tone burst evoked hearing thresholds ( Fig.   10 ) and to calculate differences in amplitude growth function (Fig. 11) . qPCR results were statistically analyzed using the Mann-Whitney test. Statistical significance was determined using α-level = 0.05 and p-values defined as *, p < 0.05; **, p < 0.01; ***, 
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Results
Developmental alterations in Ca v 3.2 transgenic mice
The 1H knockout (Ca v 3.2 -/-) mouse model exhibits cardiac pathology (Chen et al., 2003) , which is of particular significance as cardiovascular disease can promote hearing loss (Gates et al., 1993) . Given the partially controversial results on the Ca v 3.2 null mutant phenotype, we first unraveled potential developmental alterations in body weight in female and male controls (♀, n = 12; ♂, n = 11), Ca v 2.3 +/-(♀, n = 8; ♂, n = 7) and Ca v 2.3 -/-(♀, n = 8; ♂, n = 9) mice aged 140.67 ± 0.38 days. In females, a significant decrease in body weight was observed for Ca v 3.2 -/-mice compared to controls (Fig. 3) . In males, Ca v 3.2 -/-mice exhibited a significant weight reduction compared to Ca v 3.2 +/+ mice and Ca v 3.2 +/-mice (Fig. 3A) . In heterozygous mice, which do not display cardiac pathology (Chen et al., 2003) , no alterations were observed in body weight compared to controls at 20 wks of age. ). Specific emphasis was placed on the evaluation of both genders were evaluated, as gender-specific differences in auditory parameters and ARHL have been reported in both human (Pearson et al., 1995, Murphy and Gates, 1997) and mouse (Henry, 2004 , Ison et al., 2007 . ABRs to free field click (0.1 ms) and tone burst (1 -42 kHz in 6 kHz steps, 4.5 ms in total with a 1.5 ms ramp time) acoustic stimuli were recorded using subdermal electrodes (for (Fig. 6B, Fig. 7B ) and Ca v 3.2 -/-mice (Fig. 6C, Fig. 7C ).
Click related hearing thresholds in controls, Ca v 3.2 +/-and Ca v 3.2 -/-mice
To evaluate the effect of Ca v 3.2 allelic loss on general hearing performance, we analyzed click evoked ABRs for different SPLs (0 -90 dB) in all three genotypes aged 140.67 ± 0.38 days. Using our automated ABR threshold detection system, a significant difference in hearing threshold among the genotypes was detected.
Ca v 3.2 -/-mice exhibited a significant increase of hearing threshold compared to Ca v 3.2 +/+ controls (Fig. 8A, B) . The same held true in comparison to Ca v 3.2 +/-mice ( Fig. 8A, B) . Note that no gender specific alterations were observed in hearing At the age of 40 wks (280.72 ± 0.60 days), hearing thresholds significantly increased in Ca v 3.2 -/-mice compared to controls in both genders (Fig. 9) . In males, the hearing threshold of 1H null mutant mice also exceeded the threshold of Ca v 3.2 +/-mice ( Fig.   9 ). Note that no gender specific differences within the three individual genotypes however, a clear age-related increase in hearing loss was observed (p < 0.0001) (Fig. 8, Fig. 9 ). To determine potential alterations in ABR threshold levels evoked by different tone burst frequencies (1 -42 kHz, Fig. 10A, B) , we performed repeated two-way ANOVA followed by Tukey's multiple comparisons test. Significant interaction was observed for males regarding GT and stimulus frequency, whereas no significant interaction could be confirmed in female mice. Highly significant effects were observed for a GT effect and tested frequency on threshold levels. Multiple comparisons revealed significant differences for various stimulus frequencies within the frequency range of 6 -36 kHz in both Ca v 3.2 -/-female and male mice (Fig. 10A, B) .
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The percentage of animals with detectable hearing thresholds for the individual frequencies is displayed in Fig. 10C , D. Unpaired two-way ANOVA revealed a significant interaction between GT and frequency for male mice, no significant interaction for female mice and high significant effects of GT and tested frequency. (Fig. 10C, D) .
Click-evoked ABR amplitude growth function analysis
In response to moderate to high -intensity clicks there may occur up to seven ABR within the inferior colliculus (IC) on the contralateral side . It should be noted that waves II -V are likely to have more than one anatomical structure of the ascending auditory pathway contributing to them.
In 51.0 % of all click evoked ABR recordings, we identified five distinct positive waves at an SPL of 65 dB. In 25.4% of all recordings, we detected six distinct waves, and in 23.6% of all recordings, the number of identified distinct waves was limited to four . 12 ). The ABR amplitude growth function was analyzed for W I-IV (Fig. 11) (Fig. 11A, B 
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Click-evoked ABR wave latency analysis
To investigate the role of Ca v 3.2 VGCCs on temporal auditory processing within the inner ear and brainstem, we analyzed absolute click evoked wave latencies by measuring the processing time of each ABR wave (W I -W IV ). First, this analysis was performed again at 65 dB SPL because resultant ABRs exhibited best fit using the automated complex "Mexican hat" based wavelet approach.
Statistical analysis revealed that W I latency was increased in female Ca v 3.2 -/-mice compared to controls (Fig. 12A) . In males, W I latency was increased in Ca v 3.2 -/-mice compared to controls and Ca v 3.2 +/-mice (Fig. 12B) .
For W II , female Ca v 3.2 +/-and Ca v 3.2 -/-mice displayed significantly increased latency compared to controls (Fig. 12C) . In males, Ca v 3.2 -/-mice exhibited significantly increased latency compared to controls and Ca v 3.2 +/-mice (Fig. 12D) .
No differences were observed in males for W III latency (Fig. 12F) . In females, only Ca v 3.2 +/-displayed increased W III latency compared to controls, but no difference was detected for Ca v 3.2 -/-mice (Fig. 12E) . (Fig. 13A) . No alterations in IWI ΔW I,IV were observed in male transgenic animals (Fig. 13B) . Moreover, gender specific IWI differences were observed for ΔW I,IV in Ca v 3.2 +/-mice.
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In a second approach, latency analysis was performed at comparable sensation levels (20 dB above individual hearing thresholds). Under these conditions, no changes were observed in males from any of the three genotypes. In females, (Fig. 14, Fig. 15 , Table 2 ). In females, a statistical trend (p = 0.083) was detected for Ca v 3.1 transcripts in Ca v 3.2 -/-compared to controls (Fig. 14D) . In males, a statistical trend (p = 0.083) was observed for Ca v 2.3 transcripts in Ca v 3.2 -/-mice compared to controls (Fig. 15C) . Finally, a statistical trend (p = 0.065) was also observed for Ca v 2.3 transcripts between Ca v 3.2 -/-males and females.
Discussion
The pathophysiological implications of Ca v 3.2 VGCCs were previously reported to include alteration of mechanoreception (Wang and Lewin, 2011) and pain response (Choi et al., 2007 , Tsubota et al., 2018 , age-induced endothelial dysfunction (Thuesen et al., 2018) , epilepsy (Becker et al., 2008 , Zamponi et al., 2010 , retinal dysfunction (Hamby et al., 2015) , (sensory) neuronal hyperexcitability (Jacus et al., 2012 , Voisin et al., 2016 , Zhang et al., 2018 , elevated anxiety, impaired memory and reduced sensitivity to psychostimulants (Gangarossa et al., 2014) . In the auditory trace fear conditioning task, Ca v 3.2 -/-mice performed normally but were impaired in context-cued trace fear conditioning (Chen et al., 2012) . In addition, our longitudinal body weight analysis (Fig. 3B, C) indicates a complex developmental impairment, particularly in Ca v 3.2 -/-mice, which could be related to the cardiovascular phenotype, consisting of constitutively constricted coronary arterioles and focal myocardial fibrosis in Ca v 3.2 deficient animals (Chen et al., 2003 , Mizuta et al., 2010 . Of note, established cardiovascular disease and individual or combined cardiovascular disease risk factors are associated with hearing loss (Erkan et al., 2015 , Tan et al., 2018 , although there are also studies that do not support this view (Haremza et al., 2017) .
In our study, we performed gender specific analysis of both Ca v 3.2 +/-mice, which do not display a cardiac phenotype, and Ca v 3.2 -/-null mutant mice. Notably, the transgenic animals used in this study are from a C57Bl/6 background, which is important as their cochlea mimics typical characteristics of the aging human inner ear and can thus serve as a model of ARHL (presbycusis) (Ohlemiller, 2006) . Agerelated increases in ABR thresholds in the C57BL/6 strain become exacerbated approximately 8 -9 months of age, predominately above 12 kHz (Spongr et al., 1997 , Ison et al., 2007 . As experimental animals were only 5 months of age in this study, our results represent the physiological implications of Ca v 3.2 in hearing physiology rather than its implications in hearing loss. Our study demonstrates that audiometric click ABR thresholds are increased in Ca v 3.2 -/-mice from both genders compared to controls and Ca v 3.2 +/-mice at 20 wks and 40 wks of age (Fig. 8, Fig. 9 ). No significant changes were observed for heterozygous mice compared to controls.
Similar results were observed for tone burst derived ABR thresholds in both genders at the age of 20 wks (Fig. 10A, B) . Lei et al. (2011) previously reported that they did
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22 not detect any significant ABR threshold shifts in Ca v 3.2 -/-mice from 9 -11 months of age compared to controls, suggesting a preserving effect of Ca v 3.2 ablation on agerelated increases in ABR thresholds. This is in contrast to the increased click and tone burst related ABR thresholds in Ca v 3.2 -/-mice, which we observe at an earlier developmental stage (20 wks) in both genders.
Of note, Ca v 3 VGCCs exhibit a complex developmental expression pattern within the cochlea (Lei et al., 2011 , Yu et al., 2015 , Yu et al., 2016 (Yu et al., 2016) . Lei et al. (2011) analyzed all three LVA Ca v 3 transcript levels in the organ of Corti at 2, 4 and 8 months of age in which Ca v 3.2 T-type channels clearly predominate and increase with age (Lei et al., 2011) . This tendency was also confirmed in the SGN from mice 6 -44 wks old in which Ca v 3.2 transcripts represent the major T-type component (Yu et al., 2015) .
Overall, Ca v 3.2 VGCCs exhibit complex species specific spatiotemporal expression patterns in the auditory tract, particularly within the cochlea. Clearly, Ca v 3.2 expression continuously increases with age, and particularly at later stages (9 -11 months), Ca v 3.2 exerts devastating effects on SGN viability, which manifests upon Ca v 3.2 ablation (Lei et al., 2011) . However, at earlier developmental stages, e.g., 20
wks of age, our data suggest an alternative, i.e., physiological role, of Ca v 3.2 VGCCs that is distinct from its pathophysiological implications in ARHL. Indeed, the complex alterations in hearing thresholds (Fig. 8, Fig. 10 ), W I-IV amplitude growth function ( Fig. 11) and W I-IV latencies (Fig. 12) 
23 that Ca v 3.2 is a prerequisite for precise auditory information processing in young adult C57Bl/6 mice. Of note, latency analysis under comparable sensation levels revealed minor changes that may indicate a more prominent role of Ca v 3.2 VGCCs within the cochlea. In addition, it has to be considered that C57BL/6 mice, in contrast to CBA animals, display cadherin 23 related ARHL (Johnson et al., 2017) . Thus, we cannot exclude that the genetic modification of Ca v 3.2 in our mouse lines potentially interferes with cadherin 23 mutation in these animals, potentially influencing observed results (Kane et al., 2012 , Johnson et al., 2017 .
Little information is currently available regarding expression of Ca v 3.2 in the ascending auditory tract, which creates challenges in attributing specific wave amplitude and wave latency alterations to specific electrophysiological alterations at the cellular level. LVA Ca 2+ channels have been identified in Cartwheel cells of the dorsal cochlear nucleus. Cartwheel cells can fire both simple and complex action potential patterns, and early complex spike firing patterns and afterdepolarisations in these cells requires T-type and R-type Ca 2+ channels but also BK and SK channels (Kim and Trussell, 2007) . In the LSO, the firing rate of principal neurons is a linear function of interaural sound intensity differences. This type of linear response has been hypothesized to result from integration of excitatory ipsilateral and inhibitory contralateral inputs. A previous study (Adam et al., 2001c) demonstrated that this complex spike activity in rat LSO was based on T-type Ca 2+ currents, subthreshold Na + currents and hyperpolarization-activated I h conductance being sensitive to Ni 2+ , tetrodotoxin (TTX) and Cs + , respectively (Adam et al., 2001a) . Of note, Ca v 1.3
VGCCs, which are known to be relevant for auditory function in IHCs, share basic electrophysiological properties similar to those of LVA channels, such as rapid activation kinetics (Koschak et al., 2001 , Xu and Lipscombe, 2001 , Zampini et al., 2010 , Inagaki and Lee, 2013 , Zampini et al., 2013 . The latter are important for temporal aspects of sound coding and the ability to accurately trigger firing of the auditory nerve to reflect sound frequency (phase locking). Also, Ca v 1.3 channels activate at relatively negative potentials (~-70 mV in immature IHCs) which is a major property of LVA channels as well (Koschak et al., 2001 , Xu and Lipscombe, 2001 , Zampini et al., 2010 . Thus, given a RMP of ~-60 mV in these cells (Marcotti et al., 2003) , both Ca v 1.3 and Ca v 3.2 may support tonic transmitter release at rest and effectively couple increased sound intensities with higher rates of transmitter release.
Mechanistically, Ca v 3.2 might contribute to these processes by involvement in the
complex spatiotemporal interdependence of intracellular Ca 2+ levels and Ca 2+ activated K + currents (particularly via BK) in HCs as has been previously shown for Ca v 1.3 as well (Joiner and Lee, 2015) .
Despite these physiological implications, Ca 2+ influx and Ca 2+ signaling have been correlated with age-related and noise-induced neuronal cell death in HCs and SGN for some time. Consequently, T-type Ca 2+ channel blockers were thought to be otoprotective in the setting of acquired hearing loss. Early studies suggested that trimethadione, ethosuximide and flunarizine were effective in protecting SGN and NIHL (So et al., 2005; Shen et al., 2007; Lei et al., 2011) . Bao et al., (2013) confirmed this beneficial effect in NIHL for ethosuximide (Gomora et al., 2001 ) and zonisamide (Matar et al., 2009 ) for cochlear HCs and SGN. Accordingly, beneficial effects of T-type blockers on ABR threshold and SGN were also confirmed for ARHL using trimethadione, ethosuximide (Lei et al., 2011) and zonisamide (Yu et al., 2015) .
Importantly, the pharmaceutical drugs investigated have a multi-target character and do not exhibit selective T-type Ca 2+ channel blocker characteristics. In contrast, in the aforementioned studies using 9 -11 month old mice, -T-type blockers preserved ABR thresholds and prevented excessive HC and SGN loss, Yu et al. (2016) reported the inverse in younger mice aged 24 -26 wks. In a tone burst ABR setup, administration of mibefradil and benidipine did not have any beneficial impact on hearing thresholds at 8 Hz, 16 Hz and 32 kHz (despite at 24 kHz). Importantly, morphological changes were detected in IHCs and OHCs exhibiting disorganized and sparse stereocilia upon mibefradil administration and cell loss upon benidipine administration, respectively (Yu et al., 2016) .
Together with our findings, these observations clearly indicate that Ca v 3.2 VGCCs exert profound physiological effects in young adults that are tremendously important for regular auditory processing within the ascending auditory pathway. However, within settings of acquired sensorineural hearing loss related to age or noise, increased Ca v 3.2 expression levels are likely to exert devastating effects on HC and SGN viability. Thus, we propose two pharmacotherapeutic constellations that need to be clearly differentiated: 1. late-stage treatment of ARHL and acoustic injury related NIHL in which animals/patients benefit from T-type blocker administration, and 2.
Early -stage application of T-type antagonists primarily related to epilepsy treatment in infants, children and young adults. In the latter group, application of T-type blockers was reportedly exerts potential negative effects on hearing up to
25 transient/permanent hearing loss (Hori et al., 2003 , Yeap et al., 2014 , Hamed, 2017 (see also EMA side effect database, FDA adverse events reporting system (FAERS)). This is in full agreement with our findings that Ca v 3.2 is mandatory for functional and developmental integrity in the auditory system in adult mice.
Perspectives
Ca v 3.2 T-type Ca 2+ channels are expressed in HCs and SGN and T-type blockers have recently been suggested as effective for the prevention and treatment of ARHL and NIHL. Our studies demonstrate that Ca v 3.2 Ca 2+ channels mediate important physiological functions for proper auditory information processing in the cochlea and ascending auditory tract in young adult mice. This is in contrast to the suggested otoprotective function of T-type blockers during older age. Consequently, the young adult stage could represent a vulnerable phase in which T-type blockers might exert deleterious effects on the peripheral auditory system that impact potential pharmaceutical T-type blocker treatment of ARHL and NIHL.
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Figures legends (Chen et al., 2003) . The red line indicates the onset of the acoustic stimulus (y-axis scaling has been adapted in (C)). 
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